EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia

Laura Almási, Bernadett Borbála Huszti, Gábor Barna iD, Marko Kavcic, Janez Jazbec, Lennart Lenk iD, Vera Münch, Sophia Polychronopoulou, Ágnes Márk, Maria Thastrup, Lüder H Meyer, Kjeld Schmiegelow iD und 3 weitere

Pediatric Blood & Cancer · 2026-08 · 73 (8)

DOI: 10.1002/1545-5017.70405 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 01.06.2026. Verfasst von Laura Almási und 14 weiteren Autor:innen. Beteiligte Einrichtung: Paediatric Centre, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Central Nervous System Neoplasms, Practice Patterns, Physicians'. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hungarian Scientific Research Fund, Hungarian Pediatric Oncology Network, Children's Cancer and Leukemia Group.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Central nervous system (CNS) involvement in childhood acute lymphoblastic leukemia (ALL) is assessed by cell counting and cytomorphology from cerebrospinal fluid (CSF) and is used for treatment stratification worldwide. The ratio of “CNS2” patients in clinical trials ranges from 3% to 40%, with unclear prognostic significance. Procedure To assess real‐world practice, a survey was distributed globally. Questions focused on the systemic treatment allowed before the staging lumbar puncture, sample handling, methodological details of different analytics, and staging definitions.

Results

Eighty‐two centers from 47 countries from 5 continents responded. Contraindications and timing of sampling and applied CSF test modalities are heterogeneous. CSF volumes used for cytospins and flow cytometry range widely (15–3000 and 200–4000 µL, respectively). Test positivity definitions vary between ≥1 and ≥5 identified blasts for cytospin and ≥1 to ≥50 blasts for flow cytometry. Differences in practice were seen between countries in the same ALL consortium and within individual countries.

Conclusions

The observed heterogeneity impacts CNS staging and treatment decisions worldwide. Our results may explain the conflicting published evidence on the prognostic value of minimal leukemic CNS involvement. A global consensus on CNS diagnostics and a more detailed reporting of CNS staging methods in clinical studies are urgently needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaCentral Nervous System NeoplasmsPractice Patterns, Physicians'HumansChildNeoplasm StagingPrognosisFemaleChild, PreschoolMaleFlow CytometrySurveys and Questionnaires

Stichwörter der Autor:innen

acute lymphoblastic leukemiaanalyticscentral nervous systemdiagnosticsheterogeneityquestionnairesurvey

Autor:innen und Institutionen

  • Paediatric Centre, Semmelweis University, Budapest, Hungary.
  • Division of Paediatric Haematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Haematology and Infectious Diseases, Budapest, Hungary.
  • Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Children's Hospital, UMC Ljubljana, Ljubljana, Slovenia.
  • University Medical Center Ljubljana, Ljubljana, Slovenia.
  • Department of Pediatrics, Berlin-Frankfurt-Münster ALL Study Group Germany (BFM-G), University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.

ORCID-Profile: Gábor Barna, Lennart Lenk, Kjeld Schmiegelow

Förderung

  • Hungarian Scientific Research Fund
  • Hungarian Pediatric Oncology Network
  • Children's Cancer and Leukemia Group
  • Cancer Research UK Programme Foundation

Zitieren

APA

Almási, L., Huszti, B. B., Barna, G., Kavcic, M., Jazbec, J., Lenk, L., Münch, V., Polychronopoulou, S., Márk, Á., Thastrup, M., Meyer, L. H., Schmiegelow, K., Eckert, C., Halsey, C., & Erdélyi, D. J. (2026). Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer, 73(8). https://doi.org/10.1002/1545-5017.70405

Vancouver

Almási L, Huszti BB, Barna G, Kavcic M, Jazbec J, Lenk L, et al. Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer. 2026;73(8). doi:10.1002/1545-5017.70405

BibTeX
@article{Almsi2026,
  author = {Almási, Laura and Huszti, Bernadett Borbála and Barna, Gábor and Kavcic, Marko and Jazbec, Janez and Lenk, Lennart and Münch, Vera and Polychronopoulou, Sophia and Márk, Ágnes and Thastrup, Maria and Meyer, Lüder H and Schmiegelow, Kjeld and Eckert, Cornelia and Halsey, Christina and Erdélyi, Dániel J},
  title = {Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {8},
  doi = {10.1002/1545-5017.70405}
}
Kostenlos starten →